A New Treatment for Acid Sphingomyelinase Deficiency Could be Approved in the EU Soon
source: pixabay.com

A New Treatment for Acid Sphingomyelinase Deficiency Could be Approved in the EU Soon

According to a story from Globe Newswire, The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recently announced a positive opinion in regards to the experimental…

Continue Reading A New Treatment for Acid Sphingomyelinase Deficiency Could be Approved in the EU Soon
Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV
qimono / Pixabay

Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV

The new FDA-approved oral formulation of  Radicava ORS (edaravone) is more convenient than the intravenous formulation, yet the efficacy and composition remain the same. The oral formulation may also be…

Continue Reading Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV